What's in Proto Pharma Ltd's pipeline?

Proto Pharma Ltd has 1 drugs in our index: 0 marketed, 0 filed, 1 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Proto Pharma Ltd's portfolio?

Top competitors by shared drug class: London School of Hygiene and Tropical Medicine, Pfizer, University of Oxford.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/proto-pharma-ltd.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-15 · How we verify

Proto Pharma Ltd — Portfolio Competitive Intelligence Brief

Proto Pharma Ltd pipeline: 0 marketed, 0 filed, 1 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 1 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Artemether Sublingual Spray	Artemether Sublingual Spray	phase 3	Artemisinin derivative	Heme iron (parasite-derived); multiple parasite proteins and membranes	Infectious Disease

Therapeutic area mix

Infectious Disease · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

London School of Hygiene and Tropical Medicine · 1 shared drug class
Pfizer · 1 shared drug class
University of Oxford · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Proto Pharma Ltd:

Cite this brief

Drug Landscape (2026). Proto Pharma Ltd — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/proto-pharma-ltd. Accessed 2026-05-15.